Clinical trials: Small Bowel Bacterial Overgrowth
Small Intestine Bacterial Overgrowth
Study of Clinical Features and Efficacy of Small Intestinal Bacterial Overgrowth in Patients With Abdominal Distension
Most studies of bloating have focused on functional factors, while data on organic abdominal distention are rare, and studies that combine small intestine bacterial overgrowth and/or oral cecum transit time abnormalities are more…
- Trial name
- NCT06518850
- Testing
- Rifaximin
- Volunteers
- 30 people
- Sponsor
- Peking Union Medical College Hospital
SEPSIS, MALNUTRITION, CHILD
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
Children with severe malnutrition who are sick and admitted to hospitals have high mortality, usually because of infection. Malnourished children have more potentially harmful bacteria in their upper intestines than…
- Trial name
- PB-SAM (NCT04542473)
- Testing
- Pancreatic Enzyme, Ursodeoxycholic acid
- Where
- 4 sites in Bangladesh, Kenya and 2 more
- Volunteers
- 400 people
- Sponsor
- University of Oxford
Small Intestinal Bacterial Overgrowth, Elderly
Characteristic of Intestinal Flora in Male Elderly With Small Intestinal Bacterial Overgrowth
We will focus on the intestinal flora structure, risk factors and clinical features of male elderly with SIBO in our study.
- Conditions
- Small Intestinal Bacterial Overgrowth, Elderly, Male, 16s rRNA
- Trial name
- IFOSIBO (NCT03659175)
- Testing
- SIBO
- Where
- China
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Chinese PLA General Hospital
Small Intestinal Bacterial Overgrowth, Liver Cirrhosis
Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial
A total of 46 patients diagnosed with liver cirrhosis will be recruited. All patients will be evaluated with five psychometric tests and critical flicker frequency to diagnosis minimal hepatic encephalopathy (MHE).
- Trial name
- NCT02439307
- Testing
- Rifaximin
- Where
- Mexico
- Volunteers
- 11 people
- Sponsor
- Coordinación de Investigación en Salud, Mexico
Parkinson's Disease
Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth
The potential role of small bowel bacterial overgrowth (SBBO) in weight loss occurring in patients with Parkinson's Disease (PD) has not previously been examined.
- Trial name
- NCT01662791
- Testing
- Rifaximin
- Where
- United States
- Volunteers
- 49 people
- Sponsor
- Mayo Clinic
Small Intestinal Bacterial Overgrowth
Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth
This is a randomized, double-blind, placebo-controlled study to evaluate the efficacy of ciprofloxacin versus metronidazole versus placebo in eradication of small intestinal bacterial overgrowth (SIBO).
- Trial name
- NCT02458781
- Testing
- Metronidazole, Ciprofloxacin
- Volunteers
- 180 people
- Sponsor
- San Antonio Military Medical Center
Small Intestinal Bacterial Overgrowth, Irritable Bowel Syndrome
SIBO, Immune Activation, and FGIDs in Children
PURPOSE: This study will evaluate the relationships between small intestinal bacterial overgrowth (SIBO), immune activation, inflammation, and symptoms in pediatric abdominal pain-related functional gastrointestinal disorders…
- Conditions
- Small Intestinal Bacterial Overgrowth, Irritable Bowel Syndrome, Functional Dyspepsia, Functional Abdominal Pain
- Trial name
- SIBO (NCT02872961)
- Where
- United States
- Volunteers
- 54 people
- Sponsor
- The University of Texas Health Science Center, Houston
Colon Cancer
Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device
The goal of this clinical research study is to learn about gastrointestinal symptoms in participants who have undergone SC or RC and their impact on the quality of life of these participants.
- Trial name
- NCT06927011
- Testing
- Capscan
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- M.D. Anderson Cancer Center
Liver Disease
The Effect of Probiotics on Non Alcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease (NAFLD) has been suggested to be the most common cause of chronic liver disease in the general population in the Western World.
- Trial name
- NCT00808990
- Testing
- BioFemale
- Where
- Israel
- Volunteers
- 38 people, healthy volunteers welcome
- Sponsor
- Rabin Medical Center
SIBO, Small Intestinal Bacterial Overgrowth
The Low FODMAP Diet in Individuals With Small Intestinal Bacterial Overgrowth (SIBO)
This study aims to assess the impact of a low FODMAP diet (LFD) on gastrointestinal symptoms and nutritional status in individuals diagnosed with small intestinal bacterial overgrowth (SIBO).
- Conditions
- SIBO, Small Intestinal Bacterial Overgrowth, Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
- Trial name
- NCT07424313
- Testing
- Low FODMAP Diet, Healthy Eating Diet
- Where
- Poland
- Volunteers
- 51 people
- Sponsor
- Warsaw University of Life Sciences
Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth
The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin
The goal of this clinical trial is to test the effectiveness of probiotic bacterial supplements as an additional therapeutic modality in patients with small intestine bacterial overgrowth who receive oral antibiotic treatment…
- Conditions
- Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth, SIBO
- Trial name
- NCT06223685
- Testing
- Rifaximin (Xifaxan) 1200mg/day, Probiotic, XIFAXAN® (Rifaximin) 1600mg/day
- Where
- Poland
- Volunteers
- 129 people
- Sponsor
- Pomeranian Medical University Szczecin
Small Intestinal Bacterial Overgrowth, Critical Illness
Small Intestinal Bacterial Overgrowth in Critically Ill Patients
Small intestinal bacterial overgrowth (SIBO) syndrome, though associated with potentially serious complications, has not been adequately studied to date in critically ill patients hospitalized in intensive care units (ICU).
- Conditions
- Small Intestinal Bacterial Overgrowth, Critical Illness, Intensive Care Unit
- Trial name
- NCT05765994
- Testing
- Modified hydrogen breath test
- Where
- Greece
- Volunteers
- 52 people
- Sponsor
- University of Ioannina
Gastrointestinal Motility Disorder, Intestinal Disease
Lanreotide in the Treatment of Small Bowel Motility Disorders
This is a human research study looking at the effectiveness of Lanreotide (study medication) in treating small bowel motility disorders.
- Trial name
- NCT03012594
- Testing
- Lanreotide
- Where
- 2 sites in United States
- Volunteers
- 12 people
- Sponsor
- Northwell Health
Gulf War Syndrome
Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex
The adverse impact of Gulf War Syndrome (GWS) on the health of veterans and on the resources of the VA Healthcare System underscores the need to resolve its underlying cause.
- Trial name
- NCT00956150
- Testing
- Lactulose Breath Test, Rifaximin
- Where
- United States
- Volunteers
- 210 people, healthy volunteers welcome
- Sponsor
- Henry C. Lin, MD
Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth
Gulf War Digestive Health Study
The purposes of this study are to estimate the burden of disease due to chronic gastrointestinal illness in PG veterans, to evaluate whether Small Bowel Bacterial Overgrowth (SBBO) is associated with chronic diarrhea in PG…
- Trial name
- NCT00680836
- Testing
- Rifaximin
- Where
- United States
- Volunteers
- 54 people
- Sponsor
- US Department of Veterans Affairs
SIBO
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
Abdominal bloating is a common clinical symptom in the digestive system, with obscure origins and complex mechanisms. Its etiology can be attributed to organic diseases and various Functional Gastrointestinal Disorders (FGIDs).
- Trial name
- NCT06772064
- Testing
- Rifaximin (drug)
- Where
- China
- Volunteers
- 115 people, healthy volunteers welcome
- Sponsor
- Xiuli Zuo
Small Intestinal Bacterial Overgrowth, Small Intestinal Fungal Overgrowth
SIBO & SIFO After Colectomy
After subtotal colectomy, 40% of patients report abdominal pain, gas and diarrhea, and poor quality of life; whose etiology is unknown.
- Conditions
- Small Intestinal Bacterial Overgrowth, Small Intestinal Fungal Overgrowth, Colectomy
- Trial name
- NCT03216239
- Volunteers
- 100 people
- Sponsor
- Augusta University
Malabsorption Syndromes
Validation of Breath Tests in Diagnosing Small Bowel Bacterial Overgrowth
Normally the gastrointestinal tract is only sparsely colonized with bacteria. The normal flora of the duodenal or jejunal aspirate contains no more than 10^5 bacteria per milliliter.
- Trial name
- BTO (NCT00872092)
- Testing
- Stable-isotope labeled lactose ureide breath test
- Where
- Germany
- Volunteers
- 22 people
- Sponsor
- University Hospital, Bonn
Small Intestinal Bacterial Overgrowth
Comparative Assessment of Radioisotope Glucose and Breath Test
This is a research study about improving our diagnostic method for small intestinal bacterial overgrowth (SIBO). Patients undergoing Standard of Care (SOC) Endoscopically assisted glucose breath test (EAGBT) will undergo upper…
- Trial name
- NCT04499742
- Testing
- Using Isotope (Tc99m-Sulfur Colloid) to label glucose and administer this directly into duodenum.
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Augusta University
Autoimmune Gastritis
Assessing the Prevalence and Epidemiological Characteristics of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Autoimmune Gastritis(AIG) Through Hydrogen and Methane Breath Testing(HMBT).
Evaluate the prevalence of small intestinal bacterial overgrowth in patients with autoimmune gastritis (AIG) through hydrogen and methane breath testing, and determine whether there are differences in the positive rates of…
- Trial name
- HMBT、SIBO、AIG (NCT06946706)
- Testing
- hydrogen and methane breath testing
- Where
- China
- Volunteers
- 220 people
- Sponsor
- RenJi Hospital